Wolfe Research analyst Myles Walton initiates coverage on Barnes Gr (NYSE:B) with a Peer Perform rating.
Akebia Announces UK MHRA Approval Of Vafseo For The Treatment Of Symptomatic Anemia Associated With Chronic Kidney Disease In Adults On Chronic Maintenance Dialysis
Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Vafseo® (vadadustat), an